GLP-1 Microdosing refers to the use of lower-than-standard doses of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) or liraglutide (Victoza, Saxenda)
However, in a follow-up study, once participants stopped the medication, they regained about two-thirds of the weight within a year
4 Ozempic (Semaglutide 0.25 mg, 0.5 mg, 1 mg, & 2 mg) subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity and overweight
Hoffman S, Adeli K
Unopened pens should be stored in a refrigerator at 28C and must not be frozen
Evaluation of the long-term effects of urena lobata root extracts on blood glucose and hepatic function of normal rabbits